Capstone Holding reports 21.75 million shares outstanding in investor FAQ
CAPS•Shares outstanding disclosed in investor FAQ
Capstone Therapeutics disclosed about 21,750,000 shares outstanding as of Aug. 25, 2026, setting the base for total voting rights.




